These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38399228)

  • 1. The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature.
    Alzoubi A; Shirazi H; Alrawashdeh A; Al-Dekah AM; Ibraheem N; Kheirallah KA
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
    Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Research Trends in Tyrosine Kinase Inhibitors: Coword and Visualization Study.
    Hu J; Xing K; Zhang Y; Liu M; Wang Z
    JMIR Med Inform; 2022 Apr; 10(4):e34548. PubMed ID: 35072634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine.
    Xu R; Wang Q
    J Biomed Inform; 2013 Aug; 46(4):585-93. PubMed ID: 23570835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.
    Xu J; Huang Z; Gao S; Deng G; Di J
    Urol Int; 2023; 107(8):755-771. PubMed ID: 37454653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global trends and hotspots in research on organoids between 2011 and 2020: a bibliometric analysis.
    Zhang Y; Yin P; Liu Y; Hu Y; Hu Z; Miao Y
    Ann Palliat Med; 2022 Oct; 11(10):3043-3062. PubMed ID: 35948469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.
    Giri J; Moyer AM; Bielinski SJ; Caraballo PJ
    Pharmgenomics Pers Med; 2019; 12():305-318. PubMed ID: 31802928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics - a minor rather than major force in clinical medicine.
    Polasek TM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):203-212. PubMed ID: 38307498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support.
    Qin W; Lu X; Shu Q; Duan H; Li H
    Pharmacogenomics; 2022 Jan; 23(1):35-48. PubMed ID: 34787504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
    Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
    PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field.
    Chen S; Qiao Y; Chen J; Li Y; Xie J; Cui P; Huang Z; Huang D; Gao Y; Hu Y; Liu Z
    Front Oncol; 2022; 12():939838. PubMed ID: 36059661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis.
    Zhong H; Zhou Y; Mei SY; Tang R; Feng JH; He ZY; Xu QY; Xing SP
    Front Public Health; 2022; 10():967829. PubMed ID: 36203683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
    Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
    Front Immunol; 2022; 13():998217. PubMed ID: 36248874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deliberations about clinical pharmacogenetic testing in pediatric oncology.
    Issa AM; Aboushawareb SA; Eisenstat DD; Guilcher GM; Liu G; Rassekh SR; Strahlendorf C; Tallen G; Tanoshima R; Carleton B
    Per Med; 2021 Jul; 18(4):399-405. PubMed ID: 33973801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.